Location: NEW YORK, NY
CIK: 0001633313 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value ($000): $3,405,658 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOMEDICS INC | 24,500,000 | $518,420 | 15.2% | $10.77 | — | Common | 452907108 |
| — | MIRATI THERAPEUTICS INC | 3,850,200 | $496,137 | 14.6% | $21.82 | — | Common | 60468T105 |
| ASND | ASCENDIS PHARMA | 1,865,000 | $259,459 | 7.6% | $42.74 | — | Sponsored ADR | 04351P101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 8,826,039 | $244,305 | 7.2% | $10.01 | +127.2% | Common | 462260100 |
| SRPT | SAREPTA THERAPEUTICS INC | 1,760,000 | $227,110 | 6.7% | $106.97 | -5.6% | Common | 803607100 |
| — | CONSTELLATION PHARMACEUTICALS INC | 3,650,000 | $171,952 | 5.0% | $47.11 | — | Common | 210373106 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,000,000 | $169,100 | 5.0% | $84.64 | -10.8% | Common | 09061G101 |
| ARGX | ARGENX SE | 936,500 | $150,327 | 4.4% | $62.11 | — | Sponsored ADR | 04016X101 |
| — | HORIZON THERAPEUTICS PLC | 4,000,000 | $144,800 | 4.3% | $24.06 | — | Common | G46188101 |
| QURE | UNIQURE NV | 1,700,000 | $121,822 | 3.6% | $55.50 | -1.1% | Common | N90064101 |
| — | KARYOPHARM THERAPEUTICS INC | 5,900,000 | $113,103 | 3.3% | $9.62 | — | Common | 48576U106 |
| — | MYOKARDIA INC | 1,540,000 | $112,243 | 3.3% | $51.56 | — | Common | 62857M105 |
| FOLD | AMICUS THERAPEUTICS INC | 11,200,000 | $109,088 | 3.2% | $10.45 | -12.4% | Common | 03152W109 |
| — | ZOGENIX INC | 2,000,000 | $104,260 | 3.1% | $38.83 | — | Common | 98978L204 |
| — | ATHENEX INC | 5,261,437 | $80,342 | 2.4% | $18.13 | — | Common | 04685N103 |
| — | ADVERUM BIOTECHNOLOGIES INC | 5,250,000 | $60,480 | 1.8% | $10.90 | — | Common | 00773U108 |
| — | TRICIDA INC | 1,560,000 | $58,874 | 1.7% | $32.26 | — | Common | 89610F101 |
| — | AMARIN CORP PLC | 1,900,000 | $40,736 | 1.2% | $16.89 | — | Sponsored ADR | 023111206 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 349,000 | $31,797 | 0.9% | $153.98 | -37.0% | Common | 558868105 |
| XENE | XENON PHARMACEUTICALS INC | 2,400,000 | $31,464 | 0.9% | $8.86 | +18.7% | Common | 98420N105 |
| — | DECIPHERA PHARMACEUTICALS INC | 500,000 | $31,120 | 0.9% | $62.24 | — | Common | 24344T101 |
| CUE | CUE BIOPHARMA INC | 1,870,000 | $29,686 | 0.9% | $10.47 | 0.0% | Common | 22978P106 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,128,594 | $29,321 | 0.9% | $26.57 | +3.7% | Common | 019770106 |
| — | BIODELIVERY SCIENCES INTL | 3,000,000 | $18,960 | 0.6% | $3.56 | — | Common | 09060J106 |
| — | MARINUS PHARMACEUTICALS INC | 6,200,000 | $13,392 | 0.4% | $2.16 | — | Common | 56854Q101 |
| TGTX | TG THERAPEUTICS INC | 1,000,000 | $11,100 | 0.3% | $7.60 | 0.0% | Common | 88322Q108 |
| — | CYMABAY THERAPEUTICS INC | 5,500,000 | $10,780 | 0.3% | $5.32 | — | Common | 23257D103 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,105,999 | $7,167 | 0.2% | $11.09 | -51.5% | Common | 31447P100 |
| — | DECIPHERA PHARMACEUTICALS INC | 800,000 | $5,010 | 0.1% | $62.24 | — | Call | 24344T101 |
| — | ALIMERA SCIENCES INC | 415,999 | $3,153 | 0.1% | $7.58 | — | Common | 016259202 |
| — | SEATTLE GENETICS INC | 75,000 | $150 | 0.0% | — | — | Call | 812578102 |